Imlunestrant
(IM-luu-NES-trənt)
This page contains brief information about imlunestrant and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Inluriyo
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Imlunestrant is approved to treat adults with:
- breast cancer (certain types) that has spread and got worse after treatment with hormone therapy
More About Imlunestrant
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Imlunestrant - A lay language summary of important information about this drug.
Research Results and Related Resources
Targeted Therapy to Treat Cancer
Hormone Therapy for Breast Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Imlunestrant - Check for trials from ClinicalTrials.gov.